在晚期乳腺癌中的SEOM-GEICAM-SOLTI临床指南 (更新2025)
Jose Angel Garcia-Saenz1, Isabel Blancas Lopez-Barajas2, Isabel Echavarria3
1Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid, Spain. jgsaenz@salud.madrid.org.
概括
由于基因组变化,晚期乳腺癌存在治疗挑战. 这些2025年指南提供了最新的证据和疗法,以改善晚期乳腺癌患者的生活质量和生存率.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 医疗治疗 医疗治疗
背景情况:
- 晚期乳腺癌的特点是动态的基因组变化.
- 这些基因组变化有助于治疗耐药性.
- 有效的管理需要了解疾病的自然史.
研究的目的:
- 总结目前关于高级乳腺癌管理的证据.
- 概述医疗治疗的可用疗法.
- 为2025年提供更新的指南.
主要方法:
- 审查当前的科学证据.
- 分析可用的治疗选择.
- 综合数据,用于制定指南.
主要成果:
- 确定治疗耐药性的关键基因组驱动因素.
- 对治疗疗效和测序策略的评估.
- 编制最新的治疗建议.
结论:
- 个性化治疗顺序对于晚期乳腺癌至关重要.
- 为了获得最佳的患者结果,需要不断更新证据.
- 这些指南旨在提高患者的生存率和生活质量.
相关概念视频
Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Standards of Care I
1.2K
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.2K
Standards of Care II
1.1K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870


